Biotech & Pharma
Evolution of Business Models in the Biotech Industry
$3.00
Balanced Growth Strategies to Maximize Shareholder Value
$3.00
Basic Pharmaceutical Industry Scenarios
$3.00
Strategy Development
$3.00
The Transition to e-R&D is Underway
$3.00
Changes in the Clinical Process will Reflect the New Technology
$3.00
Clinical Development-Transition to Simulation
$3.00
The Shift towards Personalized Therapy
$3.00
How Different Product Models will Exist
$3.00
The New Business Model
$3.00
The Discovery process of the Future will be Biologically Based
$3.00
The Development Process of the Future
$3.00
Potential Uses of Smart Tags Across the Pharmaceutical Value Chain
$3.00
Five Steps to Successful Investigator Relationship Management
$3.00
Four Critical Aspects of ‘Best Practice’ Patient Recruitment processes
$3.00
The Path Forward
$3.00
Product Development from Scientific Discovery to Commercial product
$3.00
Clinical Development, Pharmaceutical Development and Manufacturing Facilitates
$3.00
Sales of a Drug Usually Peak about 10 Years after it has Reached the Market
$3.00
Understanding the Needs of Different Physician Segments
$3.00
The FDA’s Challenge
$3.00
Pharma will have to Make Changes Throughout the Value Chain, if it is to Meet the FDA’s Challenge
$3.00
Product Lifecycle Management
$3.00
The Shift to Targeted Treatment Solutions
$3.00
Here are Three Examples of the Future Roles the Supply Chain Might Fulfill
$3.00
The Supply Chain Transformation Agenda
$3.00
The Supply Chain will Extend its Reach to the Customer
$3.00
An Effective Drug Innovation Chain Involves Crossing Five Large Divides, Often through Alliances
$3.00
Drug Company Growth Means Business Model Progression
$3.00
Three Factors are Critical to the Industry’s Success
$3.00
The Overlapping Information Requirements
$3.00
The Actions Required for Convergence
$3.00
Market Trends and Drivers: Revolutionary Technologies and Evolutionary Practices
$3.00
Information-based Medicine Ecosystem
$3.00
